SYNLAB Group

What SYNLAB Group does

SYNLAB Group is Europe's leading medical diagnostic services provider, operating across more than 30 countries and four continents with a global headcount of 24,000-27,000 employees and approximately 600 million laboratory tests performed annually. The group was formed through the 2015 merger of Labco and SYNLAB under Cinven private equity ownership and has been listed on the Frankfurt Stock Exchange (ticker: DE000A2TSL70) since April 2021. Its core operations span pathology, molecular and genetic testing, clinical diagnostics, virology, toxicology, veterinary pathology, drug and alcohol testing, and consumer-facing health solutions.

SYNLAB UK & Ireland, the primary UK operating unit through Labco UK Group Limited, employs more than 2,600 people and executes over 45 million tests each year across an extensive laboratory network. The business model is built on long-term enterprise contracts with NHS Foundation Trusts — including 15-year and 15+ year pathology partnership agreements with Guy's and St Thomas', King's College Hospital, Mid and South Essex, and The Christie NHS Foundation Trusts — alongside direct laboratory services to hospitals, clinics, occupational health providers, and an online direct-to-consumer health testing platform. Major joint venture entities include Synnovis Group LLP, Pathology First LLP, Southwest Pathology Services LLP, and Christie Pathology Partnerships LLP.

The company pursues a buy-and-build expansion strategy, with completed acquisitions including Synergy Health Laboratory Services (2016), Geneius (2017), Lextox (2018), and Veterinary Pathology Group (2019), alongside multiple European bolt-ons. Forward-looking strategic priorities include the EU-funded VαMPiRE Parkinson's disease early-detection initiative, partnership with iFAST Diagnostics for antimicrobial susceptibility testing, and recovery from the June 2024 Synnovis ransomware cyberattack.

Name

SYNLAB Group

Legal name

SYNLAB AG

Website

https://synlab.co.uk

Company type

Public

Founded year

2021

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

SYNLAB Group is Europe's leading medical diagnostic services provider, operating across 30+ countries with 24,000-27,000 employees and 600 million tests annually. It serves NHS Foundation Trusts via long-term pathology partnerships, alongside hospitals, occupational health providers, and direct-to-consumer health testing customers.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Medical diagnostic services
• Pathology laboratory testing
• Clinical diagnostics services
• NHS pathology partnerships
• Wellness health testing

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. NHS Pathology Services Contracts: Long-term pathology partnership contracts with NHS Foundation Trusts including 15-year contracts for single provider pathology services
2. Laboratory Diagnostic Services: Comprehensive laboratory testing services including routine blood tests, virology, toxicology, molecular and genetic testing for healthcare providers, clinics, and occupational health companies
3. Health Solutions: Direct-to-consumer and business wellness testing services including online health tests for wellness needs

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

SYNLAB Group is Europe's leading medical diagnostic services provider, operating an extensive network of laboratories that deliver routine blood, virology, toxicology, molecular, and genetic testing to hospitals, clinics, occupational health companies, and NHS Foundation Trusts. The company operates long-term NHS pathology partnerships (Synnovis, Pathology First, Southwest Pathology Services, The Christie Pathology Partnership) and offers direct-to-consumer Health Solutions online health tests, supporting healthcare, wellness, sport, travel, insurance, and family law sectors.

Product overview

SYNLAB Group is a medical diagnostic services provider offering a comprehensive portfolio of laboratory testing services. The core offerings include Human Medicine (pathology diagnostic services for hospitals, labs, clinics, and occupational health), Health Solutions (online health and wellness tests), and Synnovis (NHS pathology partnership). The company operates multiple NHS partnerships including Pathology First, Southwest Pathology Services, and The Christie Pathology Partnership. Testing services span routine blood analysis, virology, toxicology, and cutting-edge molecular and genetic testing, including specific tests such as Spinal Muscular Atrophy rapid digital PCR testing. Services are delivered through an extensive network of laboratories across the UK and Ireland, supporting healthcare and wellness, sport, travel, insurance, and family law sectors.

Differentiator

Problem solved

Functional benefit

Brands

• Synnovis: A pathology partnership between Guy's and St Thomas' NHS Foundation Trust, King's College Hospitals NHS Trust and SYNLAB, providing medical diagnostic services in South East London.
• Synlab
• Health Solutions

Products and services

• Human Medicine

Quantifiable outcome

• 32 million tests per year through Synnovis partnership alone
• +2 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Six partnerships are on record, tiered strategic, flagship and core.

• VαMPiRE Project Consortium (13 European partners + Australia)strategicStrategic or Co-development Partner · 1 July 2025EU-funded research initiative led by SYNLAB's Central Laboratory in Castenedolo, Italy. Project involves 13 European partners plus one associate from Australia with €8 million in EU funding to develop an in vitro diagnostic test for early detection of Parkinson's disease.
• UEFAflagshipStrategic or Co-development Partner · 1 January 2021SYNLAB appointed as UEFA Laboratory Diagnostics Provider 2021/2022 responsible for COVID-19 testing for players, officials and venue staff at UEFA competition matches and UEFA EURO 2020. Successfully conducted over 160,000 PCR tests for UEFA competitions.
• Synnovis (Guy's and St Thomas' NHS Foundation Trust, King's College Hospitals NHS Trust)coreStrategic or Co-development PartnerSynnovis is a pathology partnership between Guy's and St Thomas' NHS Foundation Trust, King's College Hospitals NHS Trust and SYNLAB. It performs 32 million tests annually and operates the Blackfriars hub laboratory in South East London, serving GP practices across six boroughs (Bexley, Greenwich, Lewisham, Bromley, Southwark and Lambeth).
• Mid and South Essex NHS Foundation TrustcoreStrategic or Co-development Partner15-year contract signed for the delivery of a single pathology service for mid and south Essex from October 2026. SYNLAB was selected as preferred pathology services supplier following intensive competitive procurement.
• The Christie NHS Foundation TrustcoreStrategic or Co-development Partner15+ year pathology services contract with The Christie NHS Foundation Trust, a specialist cancer treatment center in Manchester. Partnership branded as Christie Pathology Partnership LLP.
• iFAST DiagnosticsstrategicTechnology or IntegrationSYNLAB UK & Ireland partnered with iFAST Diagnostics as its first commercial laboratory partner in the UK. SYNLAB is evaluating iFAST's new antimicrobial susceptibility testing (AST) system - a low-cost, high-throughput bench top device.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Unilabs: Unilabs is a leading European private clinical diagnostics and laboratory services provider operating across 16+ countries with a similar mix of routine and esoteric testing, hospital partnerships, and reference lab services — making it SYNLAB's most direct head-to-head competitor in European diagnostics outsourcing.
• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics company headquartered in Australia with operations across the US, Europe (including Germany), and Australia providing pathology, radiology, and clinical lab services — a comparable diversified diagnostics operator with similar multi-geography scale and mix of clinical and esoteric testing.
• Amedes Group: Amedes is a Germany-headquartered medical diagnostics provider specializing in laboratory medicine, pathology, and microbiology with operations across Germany, Austria, and other European countries — a direct German competitor to SYNLAB in routine and specialty clinical lab services.
• Cerba HealthCare: Cerba HealthCare is a French-headquartered European clinical diagnostics and reference laboratory group operating in Belgium, Italy, and Africa, with a comparable model of routine plus specialty testing and central reference lab operations — directly overlapping with SYNLAB's European central lab footprint.

Regional players

• HCA Healthcare UK: HCA Healthcare operates private hospitals and diagnostic services in the UK including pathology and imaging capabilities, acting as both a customer and potential competitor in UK private diagnostics — relevant to SYNLAB's commercial lab and DTC test channels.
• Medicover: Medicover is a Swedish-based healthcare and diagnostics provider operating medical clinics and laboratory services across Central and Eastern Europe (Poland, Romania, Germany, Ukraine) — comparable clinical lab and integrated diagnostics offering concentrated in geographies where SYNLAB also has or could pursue a presence.

Broad incumbents

• Laboratory Corporation of America (Labcorp): Labcorp is a global clinical laboratory and diagnostics giant with extensive routine and esoteric testing capabilities serving physicians, hospitals, employers, and consumers — a broader US-anchored incumbent with comparable portfolio breadth including genetic and molecular testing that competes for cross-border esoteric test referrals.
• Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory services company offering routine, esoteric, and anatomic pathology testing to physicians, hospitals, and employers — a much larger incumbent operating a similar reference/esoteric lab model but at substantially greater US scale, serving as a benchmark for SYNLAB's strategic direction.
• NHS England (in-house pathology services): NHS England's in-house pathology network — including NHS trusts that retain lab services in-house — represents the largest alternative provider of NHS pathology services, competing directly with SYNLAB in tenders and at re-tender, and shaping NHS policy on insourcing versus outsourcing that materially affects SYNLAB's addressable market.
• Eurofins Scientific: Eurofins Scientific is a global leader in bioanalytical testing including food, environmental, pharmaceutical, and clinical testing services across 60+ countries — overlapping with SYNLAB in the laboratory services domain but with a much broader non-clinical testing portfolio and different end-market mix.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/synlabuk
• Facebookfacebook.com/440138722705537

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries9 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A16 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SYNLAB Group